Table 5.
CEA with a health outcome: cost per HIV infection averted
| Pre-training | Post-training | |
|---|---|---|
|
Program cost |
|
|
|
Remuneration |
|
|
| Clinical staff, including counselors |
$65,000 |
$72,000 |
| Supervisory staff |
$15,000 |
$12,000 |
| Total remuneration |
$80,000 |
$84,000 |
|
Supplies, including HIV test kits and ARV drugs |
$15,000 |
$18,000 |
|
Capital (annuitized) |
|
|
| Vehicle |
$3,000 |
$3,000 |
| Equipment |
$500 |
$500 |
| Building |
$1,500 |
$1,500 |
| Training |
$0 |
$5,000 |
| Total Capital |
$5,000 |
$10,000 |
| Total program cost |
$100,000 |
$112,000 |
|
Estimate of effectiveness |
|
|
| Number of mother infant pairs that PMTCT |
1000 |
1200 |
|
Estimated vertical HIV transmission before and at birth* |
|
|
| Base case |
25% |
25% |
| Lower bound |
19% |
19% |
| Upper bound |
30% |
30% |
| Effectiveness of regimen for mothers and infant |
63% |
63% |
|
Estimated HIV infections averted |
|
|
| Base case |
(1000*.25*.63) =158 |
(1000*.25*.63) =189 |
| Lower bound |
120 |
144 |
| Upper bound |
189 |
227 |
|
Cost-effectiveness analysis |
|
|
| Incremental cost |
($112,000-$100,000) = $12,000 |
|
|
Incremental HIV infection averted |
|
|
| Base case |
|
(189–158) = 31 |
| Lower bound |
|
(144–120) = 24 |
| Upper bound |
|
(227–189) = 38 |
|
Incremental cost-effectiveness ratio (ICER) |
|
|
| Base case |
|
($12,000/31)=$283 |
| Lower bound |
|
$215 |
| Upper bound | $340 | |
*The effect of the training on MTCT is uncertain because there is a range of estimates for vertical HIV transmission before and during birth. The midpoint of the range is used to estimate effectiveness for the base case, and a sensitivity analysis is conducted with the lower and upper bounds. The base case and range are also reported for the number of HIV infections averted and ICER.